Regulation of nuclear transcription by mitochondrial RNA in endothelial cells.

chromatin chromosomes diabetes endothelial cells gene expression human immunology inflammation innate immunity lncRNA mitochondrial RNA nucleus transcription

Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
22 Jan 2024
Historique:
received: 15 01 2023
accepted: 12 12 2023
medline: 22 1 2024
pubmed: 22 1 2024
entrez: 22 1 2024
Statut: epublish

Résumé

Chromatin-associated RNAs (caRNAs) form a relatively poorly recognized layer of the epigenome. The caRNAs reported to date are transcribed from the nuclear genome. Here, leveraging a recently developed assay for detection of caRNAs and their genomic association, we report that mitochondrial RNAs (mtRNAs) are attached to the nuclear genome and constitute a subset of caRNA, thus termed mt-caRNA. In four human cell types analyzed, mt-caRNAs preferentially attach to promoter regions. In human endothelial cells (ECs), the level of mt-caRNA-promoter attachment changes in response to environmental stress that mimics diabetes. Suppression of a non-coding mt-caRNA in ECs attenuates stress-induced nascent RNA transcription from the nuclear genome, including that of critical genes regulating cell adhesion, and abolishes stress-induced monocyte adhesion, a hallmark of dysfunctional ECs. Finally, we report increased nuclear localization of multiple mtRNAs in the ECs of human diabetic donors, suggesting many mtRNA translocate to the nucleus in a cell stress and disease-dependent manner. These data nominate mt-caRNAs as messenger molecules responsible for mitochondrial-nuclear communication and connect the immediate product of mitochondrial transcription with the transcriptional regulation of the nuclear genome.

Identifiants

pubmed: 38251974
doi: 10.7554/eLife.86204
pii: 86204
doi:
pii:

Banques de données

GEO
['GSE211971', 'GSE135357']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIH HHS
ID : R01HL145170
Pays : United States
Organisme : NIH HHS
ID : R01GM138852
Pays : United States
Organisme : NIH HHS
ID : R01HD107206
Pays : United States
Organisme : NIH HHS
ID : DP1DK126138
Pays : United States
Organisme : NIH HHS
ID : R01HL106089
Pays : United States
Organisme : NIH HHS
ID : P30CA033572
Pays : United States

Informations de copyright

© 2024, Sriram et al.

Déclaration de conflit d'intérêts

KS, ZQ, DY, NM, XL, RC, YL, AT, SJ, MS, RD, BA, SP, PW, JL, RN, ZB No competing interests declared, JS JS is a co-founder of Translura, Inc, SZ SZ is a founder of Genemo, Inc

Auteurs

Kiran Sriram (K)

Department of Diabetes Complications and Metabolism, City of Hope, Duarte, United States.
Irell and Manella Graduate School of Biological Sciences, City of Hope, Duarte, United States.

Zhijie Qi (Z)

Department of Bioengineering, University of California San Diego, La Jolla, United States.

Dongqiang Yuan (D)

Department of Diabetes Complications and Metabolism, City of Hope, Duarte, United States.

Naseeb Kaur Malhi (NK)

Department of Diabetes Complications and Metabolism, City of Hope, Duarte, United States.

Xuejing Liu (X)

Department of Diabetes Complications and Metabolism, City of Hope, Duarte, United States.

Riccardo Calandrelli (R)

Department of Bioengineering, University of California San Diego, La Jolla, United States.

Yingjun Luo (Y)

Department of Diabetes Complications and Metabolism, City of Hope, Duarte, United States.

Alonso Tapia (A)

Department of Diabetes Complications and Metabolism, City of Hope, Duarte, United States.
Irell and Manella Graduate School of Biological Sciences, City of Hope, Duarte, United States.

Shengyan Jin (S)

Department of Genetics, Yale University School of Medicine, New Haven, United States.

Ji Shi (J)

Translura, Inc, New Haven, United States.

Martha Salas (M)

Department of Stem Cell Biology and Regenerative Medicine, City of Hope, Duarte, United States.

Runrui Dang (R)

Department of Bioengineering, University of California Riverside, Riverside, United States.

Brian Armstrong (B)

Department of Stem Cell Biology and Regenerative Medicine, City of Hope, Duarte, United States.

Saul J Priceman (SJ)

Department of Hematology & Hematopoietic Cell Transplantation, Department of Immuno-oncology, City of Hope, Duarte, United States.

Ping H Wang (PH)

Department of Diabetes, Endocrinology, and Metabolism, City of Hope, Duarte, United States.

Jiayu Liao (J)

Department of Bioengineering, University of California Riverside, Riverside, United States.

Rama Natarajan (R)

Department of Diabetes Complications and Metabolism, City of Hope, Duarte, United States.
Irell and Manella Graduate School of Biological Sciences, City of Hope, Duarte, United States.

Sheng Zhong (S)

Department of Bioengineering, University of California San Diego, La Jolla, United States.

Zhen Bouman Chen (Z)

Department of Diabetes Complications and Metabolism, City of Hope, Duarte, United States.
Irell and Manella Graduate School of Biological Sciences, City of Hope, Duarte, United States.

Classifications MeSH